These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 6205972
1. Monoclonal antibody (F5) to human prostate antigen. Papsidero LD, Croghan GA, Wang MC, Kuriyama M, Johnson EA, Valenzuela LA, Chu TM. Hybridoma; 1983; 2(2):139-47. PubMed ID: 6205972 [Abstract] [Full Text] [Related]
2. Monoclonal antibodies to a human prostate antigen. Frankel AE, Rouse RV, Wang MC, Chu TM, Herzenberg LA. Cancer Res; 1982 Sep; 42(9):3714-8. PubMed ID: 6179608 [Abstract] [Full Text] [Related]
3. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5. Papsidero LD, Croghan GA, Asirwatham J, Gaeta J, Abenoza P, Englander L, Valenzuela L. Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221 [Abstract] [Full Text] [Related]
4. Human prostate tissue antigens defined by murine monoclonal antibodies. Starling JJ, Sieg SM, Beckett ML, Wirth PR, Wahab Z, Schellhammer PF, Ladaga LE, Poleskic S, Wright GL. Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250 [Abstract] [Full Text] [Related]
5. Prostate-specific antigenic domain of human prostate specific antigen identified with monoclonal antibodies. Chu TM, Kawinski E, Hibi N, Croghan G, Wiley J, Killian CS, Corral D. J Urol; 1989 Jan; 141(1):152-6. PubMed ID: 2462065 [Abstract] [Full Text] [Related]
6. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW, McGuire WL. Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721 [Abstract] [Full Text] [Related]
7. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Horoszewicz JS, Kawinski E, Murphy GP. Anticancer Res; 1987 Mar; 7(5B):927-35. PubMed ID: 2449118 [Abstract] [Full Text] [Related]
8. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA). Tino WT, Huber MJ, Lake TP, Greene TG, Murphy GP, Holmes EH. Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413 [Abstract] [Full Text] [Related]
9. Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigen. Carroll AM, Zalutsky M, Schatten S, Bhan A, Perry LL, Sobotka C, Benacerraf B, Greene MI. Clin Immunol Immunopathol; 1984 Nov; 33(2):268-81. PubMed ID: 6488592 [Abstract] [Full Text] [Related]
10. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines. Chu TM, Kawinski E, Lin TH. Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940 [Abstract] [Full Text] [Related]
11. Monoclonal antibodies to human prostate and bladder tumor-associated antigens. Starling JJ, Sieg SM, Beckett ML, Schellhammer PF, Ladaga LE, Wright GL. Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915 [Abstract] [Full Text] [Related]
12. Monoclonal antibody that defines the prostate specific antigen. Donn F, Bruns T, von Meyerinck L, Schulz M, Becker WM, Becker H, Klosterhalfen H. Prostate; 1989 Aug; 14(3):237-49. PubMed ID: 2471963 [Abstract] [Full Text] [Related]
13. Monoclonal antibody to the prostate specific antigen. Donn F, Bruns T, von Meyerrinck L, Augustin C, Schulz M, Klosterhalfen H, Schmoldt A. Andrologia; 1990 Aug; 22 Suppl 1():44-55. PubMed ID: 1720289 [Abstract] [Full Text] [Related]
14. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas. Beckett ML, Lipford GB, Haley CL, Schellhammer PF, Wright GL. Cancer Res; 1991 Feb 15; 51(4):1326-33. PubMed ID: 1705172 [Abstract] [Full Text] [Related]
15. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker. Raynor RH, Hazra TA, Moncure CW, Mohanakumar T. J Natl Cancer Inst; 1984 Sep 15; 73(3):617-25. PubMed ID: 6206270 [Abstract] [Full Text] [Related]
16. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen. Bazinet M, Cote RJ, Cordon-Cardo C, Myc A, Fair WR, Old LJ. Cancer Res; 1988 Dec 01; 48(23):6938-42. PubMed ID: 2460231 [Abstract] [Full Text] [Related]
17. Production of monoclonal antibody against human prostatic adenocarcinoma and its immunohistochemical properties. Matsuki H, Ozono S, Yoshie T, Kubota K, Hirao Y, Konishi N, Hashimoto H, Ohshima M, Hiasa Y, Okajima E. Jpn J Exp Med; 1990 Oct 01; 60(5):263-72. PubMed ID: 1706786 [Abstract] [Full Text] [Related]
18. Comparative study of monoclonal antibodies TURP-27 and HNK-1: their relationship to neural cell adhesion molecules and prostate tumor-associated antigens. Lipford GB, Wright GL. Cancer Res; 1991 May 01; 51(9):2296-301. PubMed ID: 1707750 [Abstract] [Full Text] [Related]
19. Characterization of a prostate carcinoma mucin-like antigen (PMA). Beckett ML, Wright GL. Int J Cancer; 1995 Sep 15; 62(6):703-10. PubMed ID: 7558418 [Abstract] [Full Text] [Related]
20. Biochemical nature of the prostate-associated antigen identified by the monoclonal antibody, KR-P8. Raynor RH, Hazra TA, Moncure CW, Mohanakumar T. Prostate; 1986 Sep 15; 9(1):21-31. PubMed ID: 2426689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]